Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ricardo Vallejo

Pain Medicine Bloomington, IL Medical Doctor

NPI 1669469706 CMS profile 210934

1015 S Mercer Ave, Bloomington, IL 61701

Open in the dashboard

General payments

$2,323,013

760 records reported · program years 2019–2025

Research payments

$509,905

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$736,446 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ricardo Vallejo of Bloomington, IL is reported in the CMS Open Payments database as having received $2,323,013 across 760 general payments and $509,905 in research payments paid to them. Separately, studies naming them as principal investigator received $736,446 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,383 25
2024 General $66,934 85
2023 General $54,780 87
2023 Research $390,134 3
2022 General $1,869,630 135
2022 Research $104,220 4
2021 General $112,548 127
2021 Research $4,390 2
2020 General $172,478 199
2019 General $22,261 102
2019 Research $11,160 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ricardo Vallejo
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Ricardo Vallejo were reported at $24,383. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Ricardo Vallejo Pain Medicine median Middle half National median
2019 $22,261 $498 $126–$1,682 $163
2020 $172,478 $284 $80–$910 $114
2021 $112,548 $399 $112–$1,219 $132
2022 $1,869,630 $455 $137–$1,484 $149
2023 $54,780 $484 $128–$1,495 $160
2024 $66,934 $498 $131–$1,540 $164
2025 $24,383 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $2,127,515 450 payments
  2. Medtronic USA, Inc. $184,640 221 payments
  3. Avanos Medical $8,516 4 payments
  4. TerSera Therapeutics LLC $267 13 payments
  5. Nevro Corp. $245 10 payments
  6. Abbott Laboratories $228 8 payments
  7. Teva Pharmaceuticals USA, Inc. $201 10 payments
  8. Nalu Medical, Inc. $167 1 payment
  9. Allergan Inc. $163 10 payments
  10. Vertiflex, Inc. $145 1 payment
  11. Other $926 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $1,760,187 1 payment
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $444,516 233 payments
  3. Travel and Lodging $71,023 182 payments
  4. Consulting Fee $28,232 26 payments
  5. Food and Beverage $17,261 317 payments
  6. Education $1,795 1 payment
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $185,470 217 payments
  2. INTELLIS Spinal Cord Neurostimulation $92,854 92 payments
  3. INTELLIS Spinal Cord Neurostimulation $70,271 78 payments
  4. ADAPTIVESTIM $63,153 91 payments
  5. VANTA ADAPTIVESTIM $45,799 47 payments
  6. RESTORE Spinal Cord Neurostimulation $13,697 11 payments
  7. SYNCHROMED Drug Infusion Systems $13,632 10 payments
  8. SYNCHROMED Drug Infusion Systems $12,276 12 payments
  9. GENERATOR $8,516 4 payments
  10. RESTORE Spinal Cord Neurostimulation $8,481 4 payments
  11. Other $14,288 144 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $498,745 9 payments
  2. Medtronic USA, Inc. $11,160 1 payment

Records

770 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record